FUSE TECHNOLOGY - PROGRESS TO DATE

被引：0
|
作者：
NEWBERY, PG [1 ]
机构：
[1] BRUSH FUSEGEAR LTD,BURTON ON WOLDS LE12 5TH,LEICESTERSHIRE,ENGLAND
来源：
ELECTRONICS AND POWER | 1976年 / 22卷 / 02期
关键词：
D O I：
10.1049/ep.1976.0054
中图分类号：
TM [电工技术]; TN [电子技术、通信技术];
学科分类号：
0808 ; 0809 ;
摘要：
引用
收藏
页码：91 / 93
页数：3
相关论文
共 50 条
  • [41] To fuse or not to fuse
    Sakharkar, Kishore R.
    Sakharkar, Meena Kishore
    PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, 2007, : 766 - +
  • [42] TO FUSE OR NOT TO FUSE
    VANDEBOSCH, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 4 - NUCL
  • [43] TO FUSE OR NOT TO FUSE
    ATKINSON, JLD
    JOURNAL OF NEUROSURGERY, 1993, 79 (01) : 153 - 153
  • [44] Cytokine Antagonists for the Treatment of Asthma Progress to Date
    Antoniu, Sabina Antonela
    BIODRUGS, 2009, 23 (04) : 241 - 251
  • [45] Progress to Date in Advancing Stratified Medicine in Psoriasis
    Reid, Claire
    Cordingley, Lis
    Warren, Richard B.
    Griffiths, Christopher E. M.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (05) : 619 - 626
  • [46] IMS update - progress to date and future projects
    Kusuda, Y
    ASSEMBLY AUTOMATION, 1998, 18 (01) : 28 - +
  • [47] Progress to Date in Advancing Stratified Medicine in Psoriasis
    Claire Reid
    Lis Cordingley
    Richard B. Warren
    Christopher E. M. Griffiths
    American Journal of Clinical Dermatology, 2020, 21 : 619 - 626
  • [48] Pharmacotherapy for Fragile X Syndrome: Progress to Date
    Matthew H. Davenport
    Tori L. Schaefer
    Katherine J. Friedmann
    Sarah E. Fitzpatrick
    Craig A. Erickson
    Drugs, 2016, 76 : 431 - 445
  • [49] Fully Biodegradable Coronary Stents Progress to Date
    Ramcharitar, Steve
    Serruys, Patrick W.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2008, 8 (05) : 305 - 314
  • [50] Whither APEC? The progress to date and agenda for the future
    Oxley, J
    MILLENNIUM-JOURNAL OF INTERNATIONAL STUDIES, 1998, 27 (01): : 158 - 160
12345